Position in GILD
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,163,905,435
+$251,083,431 QoQ
Shares Held
15,526,336
-0.4% QoQ
Ownership
1.25%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 97.49998969492867.ToString("F0")%
None 2.500010305071332.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $19,373,328,434 across 15 Drug Manufacturers - General names. GILD ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,046,905 | $3,678,065,449 | |
| 2 | LLY |
ELI LILLY & Co
|
3,454,585 | $3,177,423,634 | |
| 3 | MRK |
Merck & Co., Inc.
|
21,855,101 | $2,628,950,086 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
15,526,336 | $2,163,905,435 | |
| 5 | AZN |
Astrazeneca PLC
|
10,103,749 | $1,992,661,366 | |
| 6 | ABBV |
AbbVie Inc.
|
7,798,048 | $1,695,997,449 | |
| 7 | AMGN |
Amgen Inc
|
4,571,725 | $1,608,561,432 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
15,509,999 | $940,681,432 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,163,905,435 | 15,526,336 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,912,822,004 | 15,584,341 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,680,504,591 | 15,139,681 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,499,098,536 | 13,521,228 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,134,718,909 | 10,126,898 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,041,740,997 | 11,277,915 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $837,185,649 | 9,985,516 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $690,739,536 | 10,067,622 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $826,257,428 | 11,279,965 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $943,669,357 | 11,648,801 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $776,630,110 | 10,363,359 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $840,836,541 | 10,910,037 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $843,843,138 | 10,170,461 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $848,495,632 | 9,883,467 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $568,634,846 | 9,217,618 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $543,786,818 | 8,797,716 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $457,986,621 | 7,703,728 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $539,326,959 | 7,427,723 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $486,998,523 | 6,972,062 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $452,579,865 | 6,572,464 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $374,055,554 | 5,787,646 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $268,129,758 | 4,602,296 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $269,227,053 | 4,260,596 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $491,606,350 | 6,389,477 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $606,812,409 | 8,116,806 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||